logoTry Persana

Tradewind BioScience - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Tradewind BioScience including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Tradewind BioScience company logo

Innovative therapeutics for the most aggressive cancers

Tradewind is dedicated to creating therapeutics for the most aggressive, difficult to treat cancers.

HeadquartersSan Francisco Bay Area, United States
Team size1-10
Founded2018

What is Tradewind BioScience? - Company Overview & Details

Tradewind BioScience is Tradewind is dedicated to creating therapeutics for the most aggressive, difficult to treat cancers. Founded in 2018, the company is headquartered in San Francisco Bay Area, United States.

Who are the Key Executives at Tradewind BioScience? - Leadership Team

Tradewind BioScience is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Tradewind BioScience

CEO

Chief Technology Officer (CTO) of Tradewind BioScience

CTO

Tradewind BioScience Company Details & Key Information

Where is Tradewind BioScience located?

Tradewind BioScience is headquartered in San Francisco Bay Area, United States.

How many employees does Tradewind BioScience have?

Tradewind BioScience has 1-10 employees.

When was Tradewind BioScience founded?

Tradewind BioScience was founded in 2018.

Tradewind BioScience Official Website

How much funding has Tradewind BioScience raised?

Tradewind BioScience has raised $120,000 across 1 funding rounds. The most recent funding was completed on 2018-02-04.

Funding Overview

Tradewind BioScience has raised a total of $120,000 in a seed funding round led by Y Combinator.

$120,000
Total Funding Raised
1
Funding Rounds
2018-02-04
Latest Round

Tradewind BioScience Funding History

Seed
2018-02-04
$120,000

Who are the key investors in Tradewind BioScience?

Tradewind BioScience is backed by 1 key investors including Y Combinator. These investors focus on Startups, Technology, Biotechnology sectors.

Tradewind BioScience Investor Overview

1
Key Investors
3
Focus Areas
0
Notable Investments

Complete List of Tradewind BioScience Investors

Y Combinator

A startup accelerator known for investing in early-stage companies.

Investment Focus
Startups
Technology
Biotechnology

What sectors do Tradewind BioScience investors focus on?

The investors backing Tradewind BioScience primarily focus on Startups, Technology, Biotechnology sectors.

Startups
Technology
Biotechnology

Featured Investor: Y Combinator

Y Combinator

A startup accelerator known for investing in early-stage companies.

Notable Investments:

What are Tradewind BioScience's future plans?

Tradewind BioScience Continue developing therapeutics targeted at aggressive cancers.

Tradewind BioScience Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Tradewind BioScience face?

Tradewind BioScience has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Tradewind BioScience

1

Market competition

2

Regulatory approvals

What opportunities does Tradewind BioScience have?

Tradewind BioScience has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Tradewind BioScience

1

Expanding research on ovarian cancer

2

Collaborations with cancer research institutions

Tradewind BioScience Strategic Position Summary

Key Focus Areas

Tradewind BioScience is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Tradewind BioScience?

Tradewind BioScience has 2 recent news updates covering key business developments and market activities.

Tradewind BioScience News Overview

2
Recent Articles
Active
Media Coverage
2022-07-17
Latest Update

What is Tradewind BioScience in the news for?

Tradewind BioScience is currently featured in news for National Ovarian Cancer Awareness Month Proclamation and other significant business developments.

Recent News Articles About Tradewind BioScience

Article 1
2022-07-17

National Ovarian Cancer Awareness Month Proclamation

September 2022 was proclaimed as National Ovarian Cancer Awareness Month, emphasizing the need for advancing research in ovarian cancer.

Read News
Article 2
2022-11-22

Meet Ronald Buckanovich, MD, PhD

Introduction of Tradewind's Academic Founder and Scientific Advisory Board Director, a pioneer in ovarian cancer research.

Read News

Tradewind BioScience FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Tradewind BioScience including information about founders, CEO, funding history, investors, headquarters location, and company details. 15 frequently asked questions covering key information about the company.

Tradewind BioScience Questions & Answers - Company Information

Q1

What is Tradewind BioScience?

Tradewind is dedicated to creating therapeutics for the most aggressive, difficult to treat cancers.

Q2

How much funding has Tradewind BioScience raised?

Tradewind BioScience has raised a total of $$120,000 across 1 funding rounds. The most recent funding was completed on 2018-02-04.

Q3

Who are the investors in Tradewind BioScience?

Tradewind BioScience's key investors include Y Combinator.

Q4

Where is Tradewind BioScience headquartered?

Tradewind BioScience is headquartered in San Francisco Bay Area, United States.

Q5

When was Tradewind BioScience founded?

Tradewind BioScience was founded in 2018.

Q6

How many employees does Tradewind BioScience have?

Tradewind BioScience has 1-10 employees.

Q7

What is Tradewind BioScience's official website?

You can visit Tradewind BioScience's official website at https://tradewindbio.com/.

Q8

What was Tradewind BioScience's latest funding round?

Tradewind BioScience's latest funding round was a Seed round of $$120,000 completed on 2018-02-04.

Q9

What does the company do?

Tradewind is dedicated to creating therapeutics for the most aggressive, difficult to treat cancers.

Q10

How much funding?

$120,000

Q11

Latest funding date?

2018-02-04

Q12

Who are the investors?

Y Combinator

Q13

What are the challenges?

Market competition Regulatory approvals

Q14

What are the opportunities?

Expanding research on ovarian cancer Collaborations with cancer research institutions

Q15

Latest news?

September 2022 was proclaimed as National Ovarian Cancer Awareness Month, emphasizing the need for advancing research in ovarian cancer. Introduction of Tradewind's Academic Founder and Scientific Advisory Board Director, a pioneer in ovarian cancer research.

More Information About Tradewind BioScience

For additional details about Tradewind BioScience, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.